Mary Ann Johnston

850 total citations
19 papers, 631 citations indexed

About

Mary Ann Johnston is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mary Ann Johnston has authored 19 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mary Ann Johnston's work include Nutrition and Health in Aging (5 papers), Muscle Physiology and Disorders (4 papers) and Cancer Treatment and Pharmacology (4 papers). Mary Ann Johnston is often cited by papers focused on Nutrition and Health in Aging (5 papers), Muscle Physiology and Disorders (4 papers) and Cancer Treatment and Pharmacology (4 papers). Mary Ann Johnston collaborates with scholars based in United States, Canada and Australia. Mary Ann Johnston's co-authors include James T. Dalton, Michael L. Hancock, Mitchell S. Steiner, Nashat Gabrail, Ralph V. Boccia, Adrian S. Dobs, Ryan P. Taylor, Jeffrey Crawford, Richard J. Gralla and Carla M. Prado and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

Mary Ann Johnston

17 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Ann Johnston United States 9 269 214 136 136 104 19 631
Domingo Rodriguez United States 5 145 0.5× 153 0.7× 152 1.1× 162 1.2× 133 1.3× 11 529
K. Gary Barnette United States 12 158 0.6× 194 0.9× 325 2.4× 319 2.3× 187 1.8× 31 810
Albina Tummolo Italy 14 264 1.0× 199 0.9× 61 0.4× 33 0.2× 30 0.3× 39 603
Tomohito Doke United States 16 93 0.3× 427 2.0× 130 1.0× 26 0.2× 111 1.1× 24 937
Nobuhiko Nakamura Japan 15 157 0.6× 196 0.9× 41 0.3× 283 2.1× 39 0.4× 52 722
Yusong Han China 11 174 0.6× 255 1.2× 63 0.5× 89 0.7× 16 0.2× 22 560
Yu-Juei Hsu Taiwan 12 102 0.4× 363 1.7× 193 1.4× 77 0.6× 53 0.5× 20 864
Ying Yan United States 9 392 1.5× 166 0.8× 62 0.5× 158 1.2× 19 0.2× 21 673
Nadezhda Glezeva Ireland 14 57 0.2× 313 1.5× 71 0.5× 81 0.6× 56 0.5× 23 901
Maria Cristina Santona Italy 10 258 1.0× 127 0.6× 38 0.3× 106 0.8× 18 0.2× 12 530

Countries citing papers authored by Mary Ann Johnston

Since Specialization
Citations

This map shows the geographic impact of Mary Ann Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ann Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ann Johnston more than expected).

Fields of papers citing papers by Mary Ann Johnston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ann Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ann Johnston. The network helps show where Mary Ann Johnston may publish in the future.

Co-authorship network of co-authors of Mary Ann Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ann Johnston. A scholar is included among the top collaborators of Mary Ann Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ann Johnston. Mary Ann Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Johnston, Mary Ann, Sharlene Rakoczy, LaDora V. Thompson, & Holly M. Brown‐Borg. (2025). Growth hormone–deficient Ames dwarf mice resist sarcopenia and exhibit enhanced endurance running performance at 24 months. GeroScience. 47(3). 4827–4843.
2.
Thomas, Richard, Atul B. Shinagare, Michael H. Rosenthal, et al.. (2019). Computed tomographic assessment of lean body mass in patients on selective androgen receptor modulator. Clinical Imaging. 59(2). 100–103. 1 indexed citations
3.
Kinsey, Emily N., et al.. (2018). Predictors of Physical and Functional Loss in Advanced-Stage Lung Cancer Patients Receiving Platinum Chemotherapy. Journal of Thoracic Oncology. 13(9). 1294–1301. 12 indexed citations
4.
Peters, Kenneth M., Diane K. Newman, Laurence Belkoff, et al.. (2018). PD05-09 ORAL ENOBOSARM SHOWS PROMISING ACTIVITY IN POST-MENOPAUSAL WOMEN WITH STRESS URINARY INCONTINENCE: RESULTS OF A PHASE 2 STUDY. The Journal of Urology. 199(4S). 2 indexed citations
7.
Overmoyer, Beth, Ann H. Partridge, Martine Extermann, et al.. (2015). Abstract P1-13-04: Enobosarm for the treatment of metastatic, estrogen and androgen receptor positive, breast cancer. Final results of the primary endpoint and current progression free survival. Cancer Research. 75(9_Supplement). P1–13. 8 indexed citations
8.
Overmoyer, Beth, Pedro Sanz-Altamira, Ryan P. Taylor, et al.. (2014). Enobosarm: A targeted therapy for metastatic, androgen receptor positive, breast cancer.. Journal of Clinical Oncology. 32(15_suppl). 568–568. 23 indexed citations
9.
Crawford, Jeffrey, Mary Ann Johnston, Ryan P. Taylor, James T. Dalton, & Mitchell S. Steiner. (2014). Enobosarm and lean body mass in patients with non-small cell lung cancer.. Journal of Clinical Oncology. 32(15_suppl). 9618–9618. 16 indexed citations
10.
Dobs, Adrian S., Ralph V. Boccia, Nashat Gabrail, et al.. (2013). Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. The Lancet Oncology. 14(4). 335–345. 279 indexed citations
11.
Vogel, Charles L., et al.. (2013). Toremifene for Breast Cancer: A Review of 20 Years of Data. Clinical Breast Cancer. 14(1). 1–9. 65 indexed citations
13.
Johnston, Mary Ann, et al.. (2011). Gastrointestinal: Refractory ulcerative colitis complicated by colonic stricturing endometriosis. Journal of Gastroenterology and Hepatology. 27(1). 181–181. 3 indexed citations
14.
Segal, Roanne, et al.. (2001). Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline.. PubMed. 8(1). 1184–92. 15 indexed citations
15.
Friedel, Godehard, Ugo Pastorino, Philippe Girard, et al.. (1999). [Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases--the International Registry of Lung Metastases].. PubMed. 124(2). 96–103. 66 indexed citations
17.
Johnston, Mary Ann. (1983). Historical recreation geography of tourist lodges: the example of Algonquin Park, Ontario.. 10(3). 22–33. 1 indexed citations
18.
Skinner, Anne R., et al.. (1978). Dallas Archaeological Potential - Procedures For Locating and Evaluating Prehistoric Resources. 2 indexed citations
19.
Johnston, Mary Ann, et al.. (1967). Germfree Isolators. AJN American Journal of Nursing. 67(1). 72–72. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026